Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | GLA | P06280 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10527280 | 0.82 | MAOA (0.57) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL525342 | 0.82 | MAOA (0.52) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL7552792 | 0.82 | GPR3 (0.44) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL13445183 | 0.79 | KDM4E (0.56) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL27110189 | 0.77 | KDM4E (0.44) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL7607540 | 0.75 | GPR3 (0.54) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL9980118 | 0.74 | ALDH1A1 (0.52) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL28158574 | 0.74 | KDM4E (0.41) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL851828 | 0.73 | KDM4E (0.44) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 | |
| SCHEMBL311283 | 0.73 | KDM4E (0.44) | KDM4EALDH1A1GLAHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2025080590-A1 | CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-17 | — | — | WO | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| US-20240066022-A1 | DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION | PURDUE RESEARCH FOUNDATION (US) | 2024-02-29 | — | — | US | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| EP-4232004-A1 | FRACTAL FORMULATIONS | Nanogyre Sprl (BE) | 2023-08-30 | — | — | EP | claimed |
| EP-3113843-B1 | COMPOSITION AND METHOD FOR ENHANCING WOUND HEALING | TUFFLEY MARK (AU) | 2022-12-14 | — | — | EP | claimed |
| WO-2021078412-A1 | FRACTAL FORMULATIONS | MESSADEK JALLAL (BE) | 2021-04-29 | — | — | WO | claimed |
| US-20210100787-A1 | DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION | PURDUE RESEARCH FOUNDATION (US) | 2021-04-08 | — | — | US | claimed |
| CN-1960763-A | Anti-vaginitis compositions | EDKO TRADING REPRESENTATION (TR) | 2007-05-09 | — | — | CN | claimed |
| CN-1826129-A | Methods and compositions relating to isoleucine boroproline compounds | POINT THERAPEUTICS INC (US) | 2006-08-30 | — | — | CN | claimed |
| CN-1703206-A | Plaster for the treatment of dysfunctions and disorders of nail growth | TROMMSDORFF ARZNEIMITTEL (DE) | 2005-11-30 | — | — | CN | claimed |
| WO-2005087270-A1 | ANTI-VAGINITIS COMPOSITIONS COMPRISING A TRIAZOLE | EDKO TRADING AND REPRESENTATION CO. LTD. (TR) | 2005-09-22 | — | — | WO | claimed |
| CN-1575165-A | Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole | TROMMSDORFF ARZNEIMITTEL (DE) | 2005-02-02 | — | — | CN | claimed |
| CN-1324607-A | Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt | TARO PHARMA IND (IL) | 2001-12-05 | — | — | CN | claimed |
| WO-2001079349-A1 | UREA MOULDING COMPOUNDS WITH ANTISEPTIC ACTIVITY | PERSTORP CHEMITEC S.P.A. (IT) | 2001-10-25 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-0305968-A2 | Compositions against protozoal diseases | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1989-03-08 | — | — | EP | claimed |
| US-4485091-A | HYDROGEN PEROXIDE, OIL IN WATER EMULSION | QUINODERM LIMITED (GB) | 1984-11-27 | — | — | US | claimed |